Advertisement
Advertisement
REGN
Regeneron Pharmaceuticals Inc
739.57
USDSponsored
-2.55
-0.34%
Oct 08, 15:59 UTC -4
Closed
Pre-Market
736.18
-3.39
-0.46%
Regeneron Pharmaceuticals Inc Financial Snapshot
| Market Cap | 75.79B |
| Beta | 0.16 |
| Earnings Per Share (EPS) | 40.46 |
| Price-to-Book (P/B) Ratio | 2.40 |
| Operating Margin | 27.17% |
| Total Debt/Equity (D/E) | 8.54% |
| P/E Ratio | 18.96 |
| Return on Equity (ROE) | 13.47% |
| Current Ratio | 3.34% |
| Free Cash Flow | 1.42B |
